- Home
- PAVM vs IINN Comparison
PAVM vs IINN Comparison
Compare PAVM & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVM
- IINN
- Stock Information
- Founded
- PAVM 2014
- IINN 2018
- Country
- PAVM United States
- IINN Israel
- Employees
- PAVM N/A
- IINN N/A
- Industry
- PAVM Medical/Dental Instruments
- IINN Medical/Dental Instruments
- Sector
- PAVM Health Care
- IINN Health Care
- Exchange
- PAVM Nasdaq
- IINN Nasdaq
- Market Cap
- PAVM 12.0M
- IINN 13.7M
- IPO Year
- PAVM 2016
- IINN 2021
- Fundamental
- Price
- PAVM $0.58
- IINN $0.75
- Analyst Decision
- PAVM Strong Buy
- IINN Strong Buy
- Analyst Count
- PAVM 1
- IINN 1
- Target Price
- PAVM $19.00
- IINN $2.00
- AVG Volume (30 Days)
- PAVM 162.2K
- IINN 880.0K
- Earning Date
- PAVM 08-11-2025
- IINN 08-14-2025
- Dividend Yield
- PAVM N/A
- IINN N/A
- EPS Growth
- PAVM N/A
- IINN N/A
- EPS
- PAVM 0.96
- IINN N/A
- Revenue
- PAVM $1,993,000.00
- IINN N/A
- Revenue This Year
- PAVM N/A
- IINN N/A
- Revenue Next Year
- PAVM $455.63
- IINN N/A
- P/E Ratio
- PAVM $0.61
- IINN N/A
- Revenue Growth
- PAVM N/A
- IINN N/A
- 52 Week Low
- PAVM $0.55
- IINN $0.40
- 52 Week High
- PAVM $1.90
- IINN $1.64
- Technical
- Relative Strength Index (RSI)
- PAVM 36.65
- IINN 57.91
- Support Level
- PAVM $0.59
- IINN $0.69
- Resistance Level
- PAVM $0.65
- IINN $0.77
- Average True Range (ATR)
- PAVM 0.04
- IINN 0.07
- MACD
- PAVM -0.00
- IINN 0.00
- Stochastic Oscillator
- PAVM 5.09
- IINN 64.22
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.